Casting a Wide Net for Wide Complex Tachycardia 1/2
A 40 yo female is brought into the emergency department. The patient is unresponsive, hypotensive, and tachycardic. EMS providers are assisting ventilations with a bag valve masked and have attempted defibrillation without success. Paramedics state that the patient was somnolent prior to the arrest and has no cardiac history. A 12 lead ECG is obtained upon arrival at the emergency department.
BP: 80/50
P: 150
R: 12/assisted
Spo2: 100% via BVM
Initial 12 lead
This is a wide complex, regular tachycardia. The widespread concordance across the precordial leads (and regular rhythm) suggest a ventricular rhythm. This rhythm was correctly interpreted- and treated- by the responding paramedics. Unfortunately, this dysrhythmia was refractory to prompt defibrillation. Why ?
Lead aVR
In addition to the wide complex tachycardia and concurrent hypotension, there is a HUGE terminal R wave (positive deflection) in lead aVR. This is a well recognized feature of tricyclic anti-depressant toxicity. Sodium channel blockade results in prolongation of the QRS and is also responsible for the hypotension. The clinical progression of TCA toxicity also involves alpha receptor blockade. Hypotension and loss of consciousness are associated with mortality in the setting of TCA toxicity.
So, what can EMS providers do?
1. Early defibrillation
2. Empiric administration of bolus sodium bicarbonate 50-100 mEQ IV/IO
3. If TCA overdose is suspected, consider vasopressors. An alpha agonist such as levophed (norepinephrine) is more ideally suited for this scenario
4. Early airway protection
5. Be very cautious with charcoal as patients with TCA toxicity experience a precipitous decrease in LOC and are at risk for aspiration. Activated charcoal produces a very nasty chemical pneumonitis.
Any other cutting edge therapies?
The use of a lipid emulsion has been studied as a treatment for suspected TCA overdose. In addition to vasopressors and fluid boluses, the lipid emulsion is thought to reduce the drug's bioavailability. Essentially, administration of a lipid emulsion can "remove" active metabolites from the intravascular compartment. The usual initial dose of a lipid emulsion is: 1.5mL/kg of a 20% solution. The bolus dose is given over one minute and is usually followed by a 400 mL infusion over 30 minutes or less.